The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Raised by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 199,170 shares of the medical device company's stock after acquiring an additional 11,568 shares during the quarter. Canada Pension Plan Investment Board owned 0.10% of Cooper Companies worth $18,310,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Cooper Companies during the fourth quarter valued at $691,000. Highland Capital Management LLC acquired a new position in shares of Cooper Companies in the fourth quarter valued at approximately $4,004,000. Caprock Group LLC purchased a new position in shares of Cooper Companies during the fourth quarter valued at approximately $282,000. Franklin Resources Inc. grew its stake in Cooper Companies by 194.0% in the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock worth $5,265,000 after acquiring an additional 32,260 shares during the period. Finally, Principal Financial Group Inc. raised its holdings in Cooper Companies by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after acquiring an additional 14,687 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 2.0 %

Shares of NASDAQ:COO traded down $1.69 during mid-day trading on Friday, hitting $80.89. 1,149,774 shares of the company traded hands, compared to its average volume of 1,421,257. The firm's 50 day simple moving average is $82.26 and its 200 day simple moving average is $92.95. The firm has a market cap of $16.18 billion, a P/E ratio of 41.48, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on COO shares. BNP Paribas raised Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Stifel Nicolaus dropped their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.